IMPLANTABLE HORMONAL CONTRACEPTIVES - EMERGING CONTROVERSY

There is an emerging policy debate over the inclusion of Norplant ince ntives in welfare reform. Even if women were guaranteed access to the implant and payment for its removal were assured, the possibility of i ncreased human immunodeficiency virus infection would remain a strong argument against its use. Although this article focuses on Norplant, m any of the arguments apply to other long-acting contraceptives that ma y become available in the future.